Effect of danazol on dysfunctional C 1 inhibitor in a patient with angioedema.
D000799:Angioedema / Q000188:drug therapy* / Q000276:immunology; D003172:Complement C1 / Q000032:analysis*; D003169:Complement Inactivator Proteins / Q000502:physiology*; D003613:Danazol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011245:Pregnadienes / Q000627:therapeutic use*
D003172:Complement C1; D003169:Complement Inactivator Proteins; D011245:Pregnadienes; D003613:Danazol